Baxter Recalls 100mL Dextrose IV Due to Particulate Matter
Baxter Healthcare recalls 105,216 containers of 5% Dextrose Injection due to foreign particulate matter. Check lot P285288.
Stop using this now
Presence of Paticulate Matter; Baxter is issuing a voluntary recall for these IV solutions due to particulate matter found in the solution identified as polyester and cotton fibers, adhesive-like mixture, polyacetal particles, thermally degraded PVC, black polypropylene and human hair embedded in the plastic bag
Contact the company
What happened, in plain English
Baxter Healthcare Corp. is recalling 105,216 containers of 5% Dextrose Injection, USP (100 mL) because the solution contains visible foreign particles. These contaminants include polyester and cotton fibers, adhesive-like mixtures, polyacetal particles, thermally degraded PVC, black polypropylene, and human hair embedded in the plastic bag. The record does not specify a remedy or action for patients. Read more at govinfonow.com/recall/46389-baxter-healthcare-corp-recalls-5-dextrose-injection-usp-100-ml.
Source Summary by GovInfoNow · govinfonow.com/recall/46389-baxter-healthcare-corp-recalls-5-dextrose-injection-usp-100-ml · Updated October 13, 2026 · FDA enforcement record: FDA #D-1162-2014
Cite this page
“Baxter Recalls 100mL Dextrose IV Due to Particulate Matter.” GovInfoNow, updated October 13, 2026. https://govinfonow.com/recall/46389-baxter-healthcare-corp-recalls-5-dextrose-injection-usp-100-ml. Based on FDA recall #D-1162-2014 (https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1162-2014%22&limit=1).
Why it’s dangerous
The IV solution contains particulate matter such as fibers, plastic fragments, and hair. Introducing these foreign objects directly into a patient's bloodstream via injection can cause serious medical complications, including blockages or infections, although the record does not detail specific injuries.
Who’s affected
Patients receiving intravenous fluids at hospitals, clinics, or other medical facilities nationwide and in Puerto Rico, Singapore, Saudi Arabia, and the United Arab Emirates are affected. Healthcare providers administering this specific lot are most at risk of delivering contaminated fluid.
How to tell if you have this one
Look for 5% Dextrose Injection, USP, in 100 mL single-dose VIAFLEX plastic containers. The product code is 2B0089 and the NDC is 0338-0017-38. Specifically check for Lot # P285288 with an expiration date of 11/13.
- Brand
Baxter Healthcare- Category
Drug
All 2 products in this recall
FDA lists each product line separately under one recall event. Check your product description, lot or code numbers against each row. Every row shares the hazard and remedy on this page.
- Classification
Class I- Status
Terminated- Distribution
Nationwide, Puerto Rico, Singapore, Saudi Arabia and United Arab Emirates.
| Recall number | Product, codes & lots | Quantity | NDC |
|---|---|---|---|
| D-1162-2014 | 5% Dextrose Injection, USP, 100 mL Single dose VIAFLEX plastic containers, Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA, Product code 2B0089, NDC 0338-0017-38.; Lot #: P285288, Exp 11/13 | 105,216 containers | 0338-0017-10, 0338-0017-41, 0338-0017-11, 0338-0017-31, 0338-0017-48, 0338-0017-18, 0338-0017-38, 0338-0017-02, 0338-0017-03, 0338-0017-04, 0338-0023-02, 0338-0023-03, 0338-0023-04 |
| D-1163-2014 | 0.9% Sodium Chloride Injection, USP, packaged in a) 50 mL Single dose VIAFLEX plastic containers (Product code 2B1308, NDC 0338-0049-31) and b) 100 mL Single dose VIAFLEX plastic containers (Product code 2B1302, NDC 0338-0049-18) and (Product code 2B1309, NDC 0338-0049-38), Rx only, Baxter Healthcare Corporation, Deerfield, IL 60015 USA.; Lot #: a) P297283, Exp 08/14; b) P292326, Exp 04/14; P293993, Exp 05/14; and P293514, Exp 04/14 | 716,544 containers | 0338-0049-01, 0338-0049-02, 0338-0049-03, 0338-0049-04, 0338-0049-10, 0338-0049-41, 0338-0049-11, 0338-0049-31, 0338-0049-48, 0338-0049-18, 0338-0049-38, 0338-0043-03, 0338-0043-04 |
What to do — step by step
Check Inventory
Verify if you have containers matching Product Code 2B0089, NDC 0338-0017-38, and Lot # P285288.
Stop Use
Do not administer the fluid if it contains visible particulate matter like fibers or plastic fragments.
Where it went and when
Where it was distributed
Distributed nationwide, and outside the U.S.
FDA distribution: “Nationwide, Puerto Rico, Singapore, Saudi Arabia and United Arab Emirates.” States read from FDA’s own wording; “not listed” means the notice does not name it.
Distributed nationwide, and outside the U.S.
Recall timeline
FDA terminated this recall 2.8 years after the firm started it.
- Firm started the recall
- FDA classified it Class I
- Published in FDA’s Enforcement Report
- FDA terminated the recall
Dates from the agency record only; steps without a date are left out.
Similar recalls
Latest drug recalls
Keep exploring
Where this comes from
The facts (hazard, remedy, dates, manufacturer) are pulled from the official FDA recall record. The plain-language summary and step-by-step checklist are written by GovInfoNow to make the official notice easier to act on — they don’t replace it.
- Official source: FDA Recall #D-1162-2014 (November 21, 2013) — FDA publishes no per-recall page; this is the official machine-readable enforcement record. Search FDA recalls for D-1162-2014 to see it in context.
- Plain-language summary written by qwen3.6:35b-a3b on October 13, 2026, from the official record above. Not reviewed by a person — if it conflicts with the FDA notice, the notice is correct. Report an error on this page.
- GovInfoNow is an independent service and is not a government agency. We republish official FDA recall data; we don’t issue, amend or administer recalls.